Ads
related to: levemir manufacturer website
Search results
Results from the WOW.Com Content Network
"Novo Nordisk will phase out, then permanently discontinue Levemir in the U.S. on December 31, 2024," the company said in a statement. Novo Nordisk to discontinue Levemir insulin in U.S. market ...
The Danish drugmaker said in November it would halt U.S. sales of Levemir by the end of 2024. ... "Levemir has been off patent for a number of years and another manufacturer could produce the drug ...
Insulin detemir, sold under the brand name Levemir among others, is a long-acting modified form of medical insulin used to treat both type 1 and type 2 diabetes. [6] It is used by injection under the skin . [ 6 ]
The company makes several drugs under various brand names, including Levemir, Tresiba, NovoLog, Novolin R, NovoSeven, NovoEight, and Victoza. [1] Novo Nordisk employs more than 48,000 people globally, and markets its products in 168 countries. [7]
Levemir's U.S. sales were 1.27 billion Danish crowns ($185.6 million) in 2023. Sales of Novo's other long-acting insulin Tresiba were 1.33 billion crowns last year. ($1 = 0.9172 euros)
From or to a drug trade name: This is a redirect from (or to) the trade name of a drug to (or from) the international nonproprietary name (INN).
The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web.
Semaglutide is a medication used for the treatment of type 2 diabetes and obesity.
Ads
related to: levemir manufacturer website